Image Source: Sequent Scientific Limited
On July 14, 2025, Sequent Scientific Ltd., India’s leading animal health company, announced the re-appointment of Dr. Kamal Sharma and Mr. Milind Sarwate as Non-Executive Independent Directors for a second consecutive term of five years, effective August 25, 2025, through August 24, 2030. The decision reflects the company’s commitment to seasoned governance and strategic continuity.
About Dr. Kamal Sharma
-
Former Managing Director of Lupin Ltd. (2003–2013), where he led the company to global prominence.
-
Held leadership roles at RPG Enterprises and served on its Management Board.
Academic credentials include:
-
B.Tech in Chemical Engineering from IIT Kanpur
-
PG Diploma in Industrial Management from JBIMS
-
PhD in Economics from IIT Bombay
-
Advanced Management Program at Harvard Business School
About Mr. Milind Sarwate
-
Founder of Increate, a governance and ESG advisory firm.
-
Serves as Independent Director at Asian Paints, Mahindra Finance, CEAT, Nykaa, and Hexaware.
-
Former CFO and CHRO at Marico and Godrej, with over four decades of corporate experience.
Qualifications include:
-
Chartered Accountant
-
Cost Accountant
-
Company Secretary
-
CII-Fulbright Fellow
Governance Impact
-
Both directors bring deep expertise in pharmaceuticals, corporate strategy, and boardroom governance.
-
Their continued presence is expected to strengthen Sequent’s audit, nomination, and CSR committees, where they already serve in key roles.
Sources: Moneycontrol, Sequent Scientific, Business Standard
Advertisement
Advertisement